Continuous R&D investments is driving the global antibiotic market Posted: October 20, 2014 |
Mumbai, India – October 20, 2014 –Recent research shows that the antibiotic market has been growing steadily due to new product innovations alongwith extensive investment in research and development activity. In addition to this, other regulatory measures to control the antibiotic resistance problem are also expected to drive the antibiotics market. This report, Global Antibiotics Market 2014-2018, provides a detailed analysis of the market and focuses on the major players, recent developments and key drivers of the global antibiotics market. This comprehensive report also enables readers to understand the critical perspectives and trends that are prevalentin the market to be able to evaluate the global antibiotics market.
Market overview According to recent research, the demand for antibiotics is expected to touch USD 44.68 billion by 2016. A host of companies have nowforayed into manufacturing antibiotics. The demand for antibiotics has been growing steadily in the past few years. While aminoglycoside accounts for 79% of the total demand, other antibiotics like penicillin, tetracyclines, erythromycin, streptomycin and chloramnphenicol also have a fair share ofthe global antibiotic market. The overall market is expected to grow at a CAGR of 1.41%.
Key Trends The two keys trends that are expected to play a major role in the growth of the antibiotics market in the future are the generic competition and antibiotic resistance. The antibacterial drug market, on the other hand, is expected to witness limited growth owingto the fact that patent requirements of the major players in the market areexpected to expire soon. Due to this, a lot of companies are now engaged in the development of anti-MRSA treatment, which is expected to foster new drugs in the market.
Key Players The key players in the industry include AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, Sanofi, Bayer HealthCare, Bristol Myers Squibb, Cubist Pharmaceuticals, Daiichi Sankyo, F. Hoffmann-La Roche, and Takeda Pharmaceutical.
For further insights, click here
About Research on Global Markets Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.
For more details on the content of each report and ordering information please contact: Phone: +91 22 4098 7600 E-Mail: [email protected]
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
